Does the length of intubation affect the success of treatment for congenital nasolacrimal duct obstruction?
Komínek
Pavel
P
Department of Otolaryngology, University Hospital Ostrava, Czech Republic. pavel.kominek@fnspo.cz
Cervenka
Stanislav
S
Matousek
Petr
P
D002675:Child, Preschool; D019793:Fluorescein / Q000378:metabolism; D005456:Fluorescent Dyes / Q000378:metabolism; D006801:Humans; D007223:Infant; D007440:Intubation / Q000295:instrumentation / Q000379:methods*; D007767:Lacrimal Duct Obstruction / Q000151:congenital / Q000378:metabolism / Q000628:therapy*; D009301:Nasolacrimal Duct; D011446:Prospective Studies; D012828:Silicones; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome
D005456:Fluorescent Dyes; D012828:Silicones; D019793:Fluorescein